MYHEP DVIR

Myhep Dvir Tablet contains the active ingredients Daclatasvir and Sofosbuvir. This antiviral medication is utilized for the treatment of chronic hepatitis C virus (HCV) infections. Hepatitis C is a liver disease caused by the hepatitis C virus (HCV). Before taking Myhep Dvir Tablet, consult your doctor if you have liver issues aside from hepatitis C infection, have undergone a liver transplant, suffer from diabetes, have heart conditions, severe kidney issues, or are on dialysis. Your physician will conduct blood tests to screen for hepatitis B virus infection prior to initiating treatment with this medication, as it has the potential to reactivate the hepatitis B virus.

Reactivation of the hepatitis B virus can lead to severe liver complications and liver failure. It is crucial to notify your doctor if you are currently taking or have recently taken any medications for heart conditions. Elderly patients may be at a higher risk for side effects from Myhep Dvir Tablet and might need lower dosages or more frequent monitoring during their treatment. The safety and efficacy of this medication in pediatric patients have not been established. These drugs should only be administered to children under the supervision of a pediatric specialist.